Vogt, A.-C.S.; Roesti, E.S.; Mohsen, M.O.; Leonchiks, A.; Vogel, M.; Bachmann, M.F.
Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes. Vaccines 2021, 9, 1316.
https://doi.org/10.3390/vaccines9111316
AMA Style
Vogt A-CS, Roesti ES, Mohsen MO, Leonchiks A, Vogel M, Bachmann MF.
Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes. Vaccines. 2021; 9(11):1316.
https://doi.org/10.3390/vaccines9111316
Chicago/Turabian Style
Vogt, Anne-Cathrine S., Elisa S. Roesti, Mona O. Mohsen, Ainars Leonchiks, Monique Vogel, and Martin F. Bachmann.
2021. "Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes" Vaccines 9, no. 11: 1316.
https://doi.org/10.3390/vaccines9111316
APA Style
Vogt, A.-C. S., Roesti, E. S., Mohsen, M. O., Leonchiks, A., Vogel, M., & Bachmann, M. F.
(2021). Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes. Vaccines, 9(11), 1316.
https://doi.org/10.3390/vaccines9111316